Vimarsana
Biggest News Aggregation in the World

Page 25 - Mc Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mc Services Today - Breaking & Trending Today

Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors - Vimarsana News

Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors

EQS-News: ABIVAX / Key word: Personnel Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors 11.07.2023 /...

EQS-News: Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors - Vimarsana News

EQS-News: Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors

EQS-News: ABIVAX / Key word(s): Personnel Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as M...

Mainz Biomed Secures up to $50M in New Funding - Vimarsana News

Mainz Biomed Secures up to $50M in New Funding

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous Mainz Biomed Secures up to $50M in New Funding 29.06.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Bio...

EQS-Adhoc: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics - Vimarsana News

EQS-Adhoc: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics

EQS-Ad-hoc: Heidelberg Pharma AG / Key word(s): Miscellaneous Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeu...

Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics - Vimarsana News

Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics

EQS-Ad-hoc: Heidelberg Pharma AG / Key word(s): Miscellaneous Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics 29-Jun-2023 / 09:45 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the ...